⌘K

Home/Filings/4/0001654954-18-005777

4//SEC Filing

Hau Bosun 4

Accession 0001654954-18-005777

CIK 0001378624other

View on SEC.gov Company Profile

Filed

May 21, 8:00 PM ET

Accepted

May 22, 4:10 PM ET

Size

5.0 KB

Accession

0001654954-18-005777

Insider Transaction Report

Form 4

Period: 2018-05-18

Cellular Biomedicine Group, Inc.CBMG

Director

Transactions

Award
Non-Qualified Stock Option (right to buy) (2014 Plan)
2018-05-18+4,499→ 4,784 total
Exercise: $19.71From: 2019-04-26Exp: 2028-05-18→ Common Stock (4,499 underlying)

Footnotes (1)

[F1]This option becomes exercisable and fully vests on April 26, 2019.

Documents

1 file

4
section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Cellular Biomedicine Group, Inc.

CIK 0001378624

Entity typeother

Related Parties

1

filerCIK 0001730224

Filing Metadata

Form type: 4
Filed: May 21, 8:00 PM ET
Accepted: May 22, 4:10 PM ET
Size: 5.0 KB

View on SEC.gov